Search - tctmd.com

Displaying 941 - 960 of 2206

Sort: Relevancy | Date

News Conference News TCT 2014

Practice Patterns of Female Interventionalists Show High Volume of Complex Cases

September 14, 2014

News Conference News TCT 2014

OCT STEMI: Imaging-Guided PCI Shows Promise

September 14, 2014

News Conference News TCT 2014

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

News Conference News TCT 2014

ABSORB EXTEND: BVS Safe Out to 3 Years

September 14, 2014

News Industry News

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

September 13, 2014

News Industry News

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

September 13, 2014

News Conference News TCT 2014

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

September 13, 2014

News Industry News

Medtronic CoreValve System Sustains Positive Outcomes Through Two Years in Extreme Risk Patients

September 13, 2014

News Daily News

Link Between PCI Volume and Outcomes Remains Intact

Todd Neale

September 13, 2014

News Industry News

Large Randomized Trial Compares Use of Vascular Closure Devices to Manual Compression in Patients Undergoing Transfemoral Coronary Angiography

September 13, 2014

News Conference News TCT 2014

COMPARE II: BES, EES Show Similar Outcomes at Three Years

September 13, 2014

News Industry News

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

September 13, 2014

News Industry News

5 Year Data from Clinical Trial Studying TAVR in Patients with Severe Aortic Stenosis Demonstrates Persistent Mortality Benefit and Lower Rate of Repeat Hospitalizations Compared to Standard Therapy

September 13, 2014

News Daily News

Nonclinical Factors Substantially Affect Detection of Obstructive CAD

Yael L. Maxwell

September 13, 2014

News Conference News TCT 2014

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

September 13, 2014

News Industry News

Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations

September 12, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Daily News

With Some Caveats, SAFE-PCI Shows Positive Signs for Radial Access in Women

Yael L. Maxwell

September 02, 2014

News Daily News

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

L.A. McKeown

September 02, 2014

Advertisement

Practice Patterns of Female Interventionalists Show High Volume of Complex Cases

OCT STEMI: Imaging-Guided PCI Shows Promise

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

ABSORB EXTEND: BVS Safe Out to 3 Years

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

Medtronic CoreValve System Sustains Positive Outcomes Through Two Years in Extreme Risk Patients

Link Between PCI Volume and Outcomes Remains Intact

Large Randomized Trial Compares Use of Vascular Closure Devices to Manual Compression in Patients Undergoing Transfemoral Coronary Angiography

COMPARE II: BES, EES Show Similar Outcomes at Three Years

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

5 Year Data from Clinical Trial Studying TAVR in Patients with Severe Aortic Stenosis Demonstrates Persistent Mortality Benefit and Lower Rate of Repeat Hospitalizations Compared to Standard Therapy

Nonclinical Factors Substantially Affect Detection of Obstructive CAD

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

With Some Caveats, SAFE-PCI Shows Positive Signs for Radial Access in Women

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content